Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
 
  
   
Insider Information:   Enright Patrick G
Relationship:   10% Owner
City:   Burlingame
State:   CA
   
Insider Summary:
  
   
Companies Owned :   16    
Direct Shares   3,308,185    

Indirect Shares

  27,432,603      
Direct Value   $10,796,077    

Indirect Value

  $115,153,143      
Total Shares   30,740,788      
Total Value   $125,949,221      


Molecular Templates, Inc.
 $298 Sequenom Inc
 $0 Corcept Therapeutics Inc
 $8,497,890 Jazz Pharmaceuticals Inc
 $2,288,769 Aptinyx Inc.
 $9,120 Eargo, Inc.
 $0 Molecular Templates, Inc.
 $298 Sequenom Inc
 $0 Corcept Therapeutics Inc
 $8,497,890 Jazz Pharmaceuticals Inc
 $2,288,769 Aptinyx Inc.
 $9,120 Eargo, Inc.
 $0
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :

    6   
    1    

     Stock price went up :

    5   
    1    
     Stock price went down :
    1   
    0    
   
     Gain/Loss Ratio :
   5.0   
   1.0   
     Percentage Gain/Loss :
   95.0%
 101.2%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Molecular Templates, Inc. MTEM Director 2006-04-20 496 2007-03-01 0    Premium*  
            Sequenom Inc SQNM Director 2006-12-07 771 2006-12-07 3,333,333    Premium*  
            Corcept Therapeutics Inc CORT Director 2017-03-16 272,281 2017-03-16 114,675    Premium*  
            Jazz Pharmaceuticals Inc JAZZ Director 2023-08-14 20,946 2022-08-08 2,000    Premium*  
            Esperion Therapeutics, Inc. ESPR Director 2013-07-01 0 2015-03-19 18,361    Premium*  
            Collegium Pharmaceutical, Inc COLL 10% Owner 2015-05-12 0 2015-05-12 65,270    Premium*  
            Aimmune Therapeutics, Inc. AIMT Director 2020-10-13 0 2020-10-10 0    Premium*  
            Aptinyx Inc. APTX Director 2020-01-10 95,000 2020-01-10 3,356,746    Premium*  
            Tricida, Inc. TCDA 2018-07-02 0 2018-07-02 3,019,734    Premium*  
            Venus Concept Inc VERO 10% Owner 0 2019-11-07 3,666,119    Premium*  
            89bio, Inc. ETNB 10% Owner 2019-11-11 0 2020-11-16 891    Premium*  
            Sierra Oncology Inc SRRA 10% Owner 2020-01-29 0 2022-01-25 1,964,771    Premium*  
            Inozyme Pharma, Inc. INZY 10% Owner 2020-07-28 0 2022-04-19 4,174,379    Premium*  
            Eargo, Inc. EAR 10% Owner 2021-04-14 2,918,691 2021-04-14 5,012    Premium*  
            Vera Therapeutics, Inc. VERA Director, 10% Owner 2021-05-18 0 2023-02-06 5,144,212    Premium*  
            Lexeo Therapeutics, Inc. LXEO 10% Owner 2023-11-07 0 2023-11-07 2,567,100    Premium*  
* Premium Members only  

Records found :    169         Free Registration Required For Full Results.    Limit: 25

Download
  Page 4 of 7
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

 
3m +/-  
Form
ESPR Esperion Therapeutics, In... Director   –       •      –    2015-03-19 4 S $110.01 $55,831,597 I/I (500,000) 18,361 0 -
CORT Corcept Therapeutics Inc Director   –       •       •   2015-03-20 4 OE $2.77 $3,132,064 I/I 1,130,709 182,742 0 -
CORT Corcept Therapeutics Inc Director   –       •       •   2015-03-20 4 S $5.85 $3,132,072 I/I (535,397) 178,125 0 -
CORT Corcept Therapeutics Inc Director   –       •       •   2015-03-24 4 S $5.65 $3,132,066 I/I (554,348) 13,677,121 0 -
CORT Corcept Therapeutics Inc Director   –       •       •   2015-03-24 4 OE $2.77 $3,132,064 I/I 1,130,709 14,231,469 0 -
CORT Corcept Therapeutics Inc Director   –       •       •   2015-03-30 4 OE $4.05 $3,469,408 I/I 856,644 194,958 0 -
JAZZ Jazz Pharmaceuticals Inc Director   –       •      –    2015-04-06 4 S $168.31 $1,691,419 I/I (10,000) 6,286 0 -
JAZZ Jazz Pharmaceuticals Inc Director   –       •      –    2015-06-01 4 S $177.82 $1,787,336 I/I (10,000) 5,893 0 -
JAZZ Jazz Pharmaceuticals Inc Director   –       •      –    2015-07-06 4 S $175.81 $1,771,055 I/I (10,000) 5,696 0 -
JAZZ Jazz Pharmaceuticals Inc Director   –       •      –    2015-08-07 4 A $0.00 $0 D/D 1,310 2,960 0 -
JAZZ Jazz Pharmaceuticals Inc Director   –       •      –    2015-08-10 4 AS $179.98 $144,178 D/D (801) 2,159 0 -
JAZZ Jazz Pharmaceuticals Inc Director   –       •      –    2015-08-10 4 AS $180.05 $1,820,177 I/I (10,000) 5,500 0 -
AIMT Aimmune Therapeutics, Inc... Director   –       •       •   2015-08-11 4 B $16.00 $5,000,000 I/I 312,500 7,434,630 2.25 -
AIMT Aimmune Therapeutics, Inc... Director   –       •       •   2015-08-11 4 A $0.00 $0 I/I 7,122,130 7,122,130 0 -
JAZZ Jazz Pharmaceuticals Inc Director   –       •      –    2015-08-27 4 S $167.87 $71,345 D/D (425) 1,734 0 -
JAZZ Jazz Pharmaceuticals Inc Director   –       •      –    2015-09-01 4 S $164.50 $1,659,852 I/I (10,000) 5,304 0 -
JAZZ Jazz Pharmaceuticals Inc Director   –       •      –    2015-10-05 4 S $132.26 $1,337,860 I/I (10,000) 5,108 0 -
JAZZ Jazz Pharmaceuticals Inc Director   –       •      –    2015-11-10 4 S $128.96 $1,352,862 I/I (10,000) 4,912 0 -
JAZZ Jazz Pharmaceuticals Inc Director   –       •      –    2015-12-01 4 S $145.96 $1,465,910 I/I (10,000) 4,716 0 -
JAZZ Jazz Pharmaceuticals Inc Director   –       •      –    2015-12-02 4 S $148.49 $62,960 D/D (424) 1,310 0 -
JAZZ Jazz Pharmaceuticals Inc Director   –       •      –    2016-01-05 4 S $137.71 $1,380,890 I/I (10,000) 4,519 0 -
JAZZ Jazz Pharmaceuticals Inc Director   –       •      –    2016-02-10 4 S $114.43 $1,179,214 I/I (10,000) 4,323 0 -
AIMT Aimmune Therapeutics, Inc... Director   –       •       •   2016-03-29 4 B $13.50 $1,089,135 I/I 78,504 7,513,134 2.25 -
JAZZ Jazz Pharmaceuticals Inc Director   –       •      –    2016-08-11 4 A $0.00 $0 D/D 1,365 2,675 0 -
JAZZ Jazz Pharmaceuticals Inc Director   –       •      –    2016-08-15 4 S $136.45 $86,373 D/D (633) 2,042 0 -

  169  Records found
  1   2   3   4  5   6   7      
  Page 4 of 7  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed